Edwards Lifesciences Corp. (EW)
-NYSE 65.62 
0.75(1.13%) 1:43PM EDT - Nasdaq Real Time Price
| Prev Close: | 66.37 |
|---|
| Open: | 66.24 |
|---|
| Bid: | 65.51 x 300 |
|---|
| Ask: | 65.55 x 300 |
|---|
| 1y Target Est: | 77.61 |
|---|
| Beta: | 0.62 |
|---|
| Next Earnings Date: | 22-Jul-13 |
|---|
| Day's Range: | 64.89 - 66.28 |
|---|
| 52wk Range: | 62.34 - 110.79 |
|---|
| Volume: | 1,071,051 |
|---|
| Avg Vol (3m): | 1,404,070 |
|---|
| Market Cap: | 7.41B |
|---|
| P/E (ttm): | 20.72 |
|---|
| EPS (ttm): | 3.16 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- Positive Patient Outcomes at One Year With Edwards Sapien XT Transcatheter ValveMarketwired(Tue 10:45AM EDT)
- Medtronic’s Heart Rhythm Devices Show Signs of Growthat Bloomberg(Tue 8:59AM EDT)
- Medtronic Device Safely Fixes Aortic Value in Studyat Bloomberg(Tue 4:00AM EDT)
- Today’s 3 Worst Stocksat Motley Fool(Fri, May 17)
- Insiders are crazy about these stocksat MarketWatch(Fri, May 17)
- Why This Big Buyback Isn't a Long-Term Solutionat Motley Fool(Fri, May 17)
- 4 Stocks Underperforming Today In The Health Services Industryat TheStreet(Fri, May 17)
- EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of InEDGAR Online(Fri, May 17)
- EDWARDS LIFESCIENCES CORP Files SEC form 8-K, Change in Directors or Principal OfficersEDGAR Online(Wed, May 15)
- The Morning Ledger: Euro Zone's Biggest Economies Sputterat The Wall Street Journal(Wed, May 15)
- After the close: Edwards discovers the value of stock repurchase planat MarketWatch(Tue, May 14)
- Edwards Lifesciences CFO to Retireat Motley Fool(Tue, May 14)
- Today's 3 Best Stocksat Motley Fool(Tue, May 14)
- Sony, SodaStream, Trina Solar are big moversAP(Tue, May 14)
- Edwards Lifesciences' CFO Exit Paves Way for External Successorat The Wall Street Journal(Tue, May 14)
Key Statistics
| Forward P/E (1 yr): | 18.01 |
|---|
| P/S (ttm): | 3.87 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 3.05 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 0.76 |
|---|
| Mean Recommendation*: | 2.3 |
|---|
| PEG Ratio (5 yr expected): | 1.55 |
|---|
Business Summary
Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients worldwide. The company offers surgical heart valve therapy products, such as tissue heart valves and repair products,...
View More